胃肠道事件与骨质疏松患者生活质量及治疗满意度的关联:来自MUSIC OS研究的结果
MUSIC OS为多国前瞻性观察研究,纳入2959例接受骨质疏松治疗的患者,评估胃肠道事件与健康相关生活质量及治疗满意度的关联。基线胃肠道事件对12个月时EQ-5D、OPAQ-SV评分及治疗满意度的负面影响持续存在。胃肠道事件是生活质量下降和治疗满意度降低的独立预测因素。
要点
- 基线胃肠道事件患者12个月EQ-5D效用评分较无事件者低0.04(P≤0.001)。
- 基线胃肠道事件患者12个月OPAQ背痛评分较无事件者低8.50(P≤0.001)。
- 基线胃肠道事件患者12个月治疗满意度评分下降6.46,基线后事件者下降7.88。
核心结论
- 胃肠道事件是接受骨质疏松治疗患者健康相关生活质量下降和治疗满意度降低的独立预测因素。
研究设计与样本
- MUSIC OS为多国、前瞻性、观察性研究,评估胃肠道事件对绝经后女性骨质疏松管理的影响,本分析纳入2959例患者。
主要发现
- 每个时间点未校正评分显示,有胃肠道事件患者低于无胃肠道事件患者。
- 校正分析中,基线胃肠道事件患者12个月EQ-5D效用评分较无事件者低0.04(P≤0.001)。
- 校正分析中,基线胃肠道事件患者12个月EQ-5D视觉模拟量表评分较无事件者低5.07(P≤0.001)。
- 校正分析中,基线胃肠道事件患者12个月OPAQ身体功能、情绪状态和背痛评分分别较无事件者低3.35、4.60和8.50(P均≤0.001)。
- 12个月治疗满意度评分下降:基线胃肠道事件患者为6.46,基线后胃肠道事件患者为7.88。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The purpose of this study was to assess the association of GI events with HRQoL and treatment satisfaction. The effect of baseline GI events persisted through 1 year of follow-up, as indicated by lower EQ-5D, OPAQ-SV, and treatment satisfaction scores among patients with vs without baseline GI events. The presence of GI events is an independent predictor of decreased HRQoL and treatment satisfaction in patients being treated for osteoporosis. INTRODUCTION: The goal of this study was to assess the association of gastrointestinal (GI) events with health-related quality of life (HRQoL) and treatment satisfaction in patients being treated for osteoporosis. METHODS: MUSIC OS was a multinational, prospective, observational study examining the impact of GI events on osteoporosis management in postmenopausal women. In this analysis, HRQoL and treatment satisfaction were assessed at baseline, 6, and 12 months and compared between patients with and without GI events. Covariate-adjusted scores were calculated using multivariate least-squares regression analysis, and differences between the mean scores of patients with and without baseline and post-baseline GI events were determined. RESULTS: Among the 2959 patients in the analysis, unadjusted scores at each time point were lower (i.e., worse) for patients with GI events than patients without GI events. In adjusted analyses, the effect of baseline GI events persisted through 1 year of follow-up, as indicated by lower EQ-5D and OPAQ-SV scores at 12 months among patients with vs without baseline GI events (-0.04 for the EQ-5D utility score, -5.07 for the EQ-5D visual analog scale, -3.35 for OPAQ physical function, -4.60 for OPAQ emotional status, and -8.50 for OPAQ back pain; P ≤ 0.001 for all values). Decrements in month 12 treatment satisfaction scores were -6.46 for patients with baseline GI events and -7.88 for patients with post-baseline GI events. CONCLUSIONS: The presence of GI events is an independent predictor of decreased HRQoL and treatment satisfaction in patients being treated for osteoporosis.
引用
- Modi A, Sen S, Adachi JD, et al. Association of gastrointestinal events with quality of life and treatment satisfaction in osteoporosis patients: results from the Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC OS). Osteoporos Int. 2017. PMID: 28643048. doi:10.1007/s00198-017-4116-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。